GENE ONLINE|News &
Opinion
Blog

Drug Approval
Santhera, ReveraGen’s Duchenne Drug Accepted By EMA While Anticipating FDA Priority Review
2022-11-01
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Mounting Criticisms of FDA’s Accelerated Approval Pathway Could Prompt Changes to the System
2022-08-25
Three Previously Approved Treatments Show Anti-monkeypox Activity
2022-08-08
Everest Medicines Secures Breast Cancer Drug Approval in China
2022-06-13
WSJ Health Forum 2022: Psychedelics Set to Take Center Stage in Mental Wellness
2022-03-24
FDA Approves Drug for Schizophrenia in Pediatric Patients
2022-01-10
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
FDA Greenlights Blueprint Medicines’ Ayvakit for Rare Disease Treatment
2021-06-21
Novartis Wins Five Simultaneous Drug Approvals in Japan
2020-07-06
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top